Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | -519 | 157 | 176 | 188 |
| Accounts receivable | -41 | 9 | -15 | -7 | 5 |
| Other Working Capital | -81 | 481 | -473 | 140 | 289 |
| Other Operating Activity | -67 | -70 | 506 | -1,141 | -1,682 |
| Operating Cash Flow | $-189 | $-99 | $176 | $-832 | $-1,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | 0 | -28 |
| Sale Of Investment | N/A | 551 | 0 | N/A | N/A |
| Other Investing Activity | 0 | -20 | 0 | 83 | 0 |
| Investing Cash Flow | $N/A | $530 | $0 | $83 | $-28 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | -395 | 395 | 0 |
| Financing Cash Flow | $N/A | $0 | $-395 | $395 | $0 |
| Beginning Cash Position | 680 | 248 | 468 | 821 | 2,049 |
| End Cash Position | 491 | 680 | 248 | 468 | 821 |
| Net Cash Flow | $-189 | $432 | $-219 | $-354 | $-1,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -189 | -99 | 176 | -832 | -1,200 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -28 |
| Free Cash Flow | -189 | -99 | 176 | -832 | -1,228 |